Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 1.3B | 1.3B | 1.3B |
Cost of revenue | 106.7M | 96.3M | 92.2M | 99.9M |
Gross profit | 1.3B | 1.2B | 1.2B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 44.0M | 49.1M | 41.9M | 45.1M |
Other operating expenses | — | — | — | — |
Operating income | 620.8M | 588.2M | 594.6M | 589.0M |
Non operating interest income | ||||
Income | — | -592K | — | — |
Expense | 263.0M | 262.6M | 254.9M | 241.5M |
Other income expense | -83.4M | -96.0M | -45.8M | -63.6M |
Pretax income | 267.1M | 221.5M | 286.5M | 276.6M |
Tax provision | 15.7M | 20.1M | 15.4M | 15.6M |
Net income | 251.5M | 201.4M | 271.1M | 261.0M |
Basic EPS | 0.3 | 0.2 | 0.3 | 0.3 |
Diluted EPS | 0.3 | 0.2 | 0.3 | 0.3 |
Basic average shares | 891.7M | 875.7M | 870.7M | 870.3M |
Diluted average shares | 892.4M | 879.6M | 874.0M | 872.5M |
EBITDA | 1.2B | 1.2B | 1.2B | 1.2B |
Net income from continuing op. | 251.5M | 201.4M | 271.1M | 261.0M |
Minority interests | -1.6M | -1.7M | -1.6M | -1.6M |
Preferred stock dividends | — | 0 | 5.1M | — |